Rating History for Sanofi (SNY) by BNP Paribas Exane

More Stocks Rated by BNP Paribas Exane | Latest Ratings for SNY
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
4/20/2026 Peter Verdult Downgrade Neutral
(Outperform)		 50.00
(N/A)		 47.72
(41.33)		 -13.39% Details